iifl-logo-icon 1

Fredun Pharmaceuticals Ltd Share Price

737.35
(0.05%)
Dec 24, 2024|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open743.45
  • Day's High759.95
  • 52 Wk High1,054
  • Prev. Close736.95
  • Day's Low725
  • 52 Wk Low 650
  • Turnover (lac)33.43
  • P/E19.59
  • Face Value10
  • Book Value278.44
  • EPS37.64
  • Mkt. Cap (Cr.)346.49
  • Div. Yield0.09
View All Historical Data
No Records Found

Fredun Pharmaceuticals Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

743.45

Prev. Close

736.95

Turnover(Lac.)

33.43

Day's High

759.95

Day's Low

725

52 Week's High

1,054

52 Week's Low

650

Book Value

278.44

Face Value

10

Mkt Cap (₹ Cr.)

346.49

P/E

19.59

EPS

37.64

Divi. Yield

0.09

Fredun Pharmaceuticals Ltd Corporate Action

18 Sep 2024

12:00 AM

BookCloser

arrow

18 Sep 2024

12:00 AM

AGM

Announcement Date: 18 Sep, 2024

arrow

15 Oct 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

22 Dec 2023

12:00 AM

EGM

arrow

7 May 2024

12:00 AM

Dividend

Dividend Amount: 0.7

Record Date: 23 Sep, 2024

arrow

Fredun Pharmaceuticals Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Fredun Pharmaceuticals Ltd SHAREHOLDING SNAPSHOT

25 Dec, 2024|12:39 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 48.93%

Foreign: 0.00%

Indian: 48.93%

Non-Promoter- 1.58%

Institutions: 1.58%

Non-Institutions: 49.48%

Custodian: 0.00%

Share Price

Fredun Pharmaceuticals Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

6.27

12.86

4.64

3.99

Preference Capital

0

0

0

0

Reserves

115.2

83.52

63.42

39.08

Net Worth

121.47

96.38

68.06

43.07

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Revenue

133.89

112.77

58.06

56.69

yoy growth (%)

18.72

94.2

2.41

33.96

Raw materials

-101.77

-80.14

-39.51

-37.17

As % of sales

76

71.06

68.04

65.57

Employee costs

-8.65

-8.94

-5.18

-4.91

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

4.37

2.49

2.64

2.22

Depreciation

-2

-1.87

-1.28

-1.13

Tax paid

-1.19

-0.59

-0.89

-0.79

Working capital

7.41

38.35

2.4

0.25

Other operating items

View Cash Flow
Y/e 31 MarMar-2021Mar-2020Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

18.72

94.2

2.41

33.96

Op profit growth

10.51

95.94

27.02

-14.89

EBIT growth

23.5

50.86

11.66

3.5

Net profit growth

5.92

8.62

22.66

33.46

View Ratios

No Record Found

Fredun Pharmaceuticals Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,817.6

158.194,36,103.12863.290.745,123.6798.33

Divis Laboratories Ltd

DIVISLAB

5,783.75

83.581,53,540.395180.522,302513.62

Mankind Pharma Ltd

MANKIND

2,910.4

59.911,20,073.47634.4302,529.74334.18

Cipla Ltd

CIPLA

1,475.9

28.161,19,195.761,178.160.883,969.86360.73

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,401.2

70.361,15,106.894600.822,376222.38

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Fredun Pharmaceuticals Ltd

Management

Register Office

Registrar Office

WTD & Joint Managing Director

Daulat N Medhora

Executive Director

Nariman B Medhora

Non-Exec. & Independent Dir.

Aspi N Raimalwala

Managing Director & CFO

Fredun N Medhora

Non-Exec. & Independent Dir.

Rohinton Kanga

Company Sec. & Compli. Officer

Jinkal Shah

Additional Director

Daisy Dsouza

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Incorporated in 1987 as a private limited company, Fredun Pharmaceuticals (FPL) was converted into a public limited company in Mar.94. The Company was promoted by Nariman Medhora and Daulat N Medhora. The promoters initially established D N Pharma, a proprietary firm, for the manufacture and export of pharmaceutical formulations. Since 1993, D N Pharmas operations were phased out in order to switch over the business to FPL. The Company is well diversified in the business ranging from Formulations to Diagnostics to Consultancy. The Company has an unique range of products, from niche formulations , anti-diabetics to the latest antiretroviral and anti - Hypertensive products. It supplies finished formulations to over 42 Countries globally. It is associated with many Governments of different countries which have also realised the need for robust and consistent healthcare systems.The Company was set up with the objective of providing facilities for manufacturing and marketing of various pharmaceutical formulations like tablets, capsules, dry-syrups and ointments. It then set up a formulation unit at Palghar (Thane District), Maharashtra, which commenced commercial production in Aug.94. FPL had been carrying out manufacturing operations on loan licence for reputed pharmaceutical companies like Cipla. It also manufactured for some merchant exporters, including Merind.In Apr.96, the company came out with a public issue to register its products in the overseas market for exports; to p
Read More

Company FAQs

What is the Fredun Pharmaceuticals Ltd share price today?

The Fredun Pharmaceuticals Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹737.35 today.

What is the Market Cap of Fredun Pharmaceuticals Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Fredun Pharmaceuticals Ltd is ₹346.49 Cr. as of 24 Dec ‘24

What is the PE and PB ratio of Fredun Pharmaceuticals Ltd?

The PE and PB ratios of Fredun Pharmaceuticals Ltd is 19.59 and 2.65 as of 24 Dec ‘24

What is the 52 Week High and Low of Fredun Pharmaceuticals Ltd?

The 52-week high/low is the highest and lowest price at which a Fredun Pharmaceuticals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Fredun Pharmaceuticals Ltd is ₹650 and ₹1054 as of 24 Dec ‘24

What is the CAGR of Fredun Pharmaceuticals Ltd?

Fredun Pharmaceuticals Ltd's CAGR for 5 Years at 28.71%, 3 Years at -2.32%, 1 Year at -15.46%, 6 Month at -17.70%, 3 Month at -4.81% and 1 Month at 4.11%.

What is the shareholding pattern of Fredun Pharmaceuticals Ltd?

The shareholding pattern of Fredun Pharmaceuticals Ltd is as follows:
Promoters - 48.93 %
Institutions - 1.59 %
Public - 49.48 %

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2024, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp